| Thomas G Wuller, MD | |
|
511 S Windsor Dr, Stillwater, OK 74074 | |
| (405) 707-0900 | |
| (405) 707-3363 |
| Full Name | Thomas G Wuller |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 32 Years |
| Location | 511 S Windsor Dr, Stillwater, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215910179 | NPI | - | NPPES |
| 100057720A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 20206 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stillwater Medical Center Home Health Services | Stillwater, OK | Home health agency |
| Stillwater Medical Center | Stillwater, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stillwater Medical Center Authority | 2365353794 | 143 |
News Archive
PanGenetics, an antibody development company which is developing PG110, a humanized antibody to Nerve Growth Factor (NGF), today announced it has entered into an agreement with Abbott under which Abbott will acquire the global rights to this novel biologic. PG110 is currently in a Phase 1 clinical trial in patients with osteoarthritis and represents a promising new therapeutic for the treatment of chronic pain.
Valeant Pharmaceuticals International, Inc. and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older.
The team of María Domínguez, researcher for the Neuroscience Institute, joint venture of the Miguel Hernández University in Elche and the Spanish National Research Council, has managed to prove for the first time that an important factor in the development of acute pediatric lymphoblastic leukemia is inflammation.
Researchers at Dana-Farber Cancer Institute report that full-body PET/CT scanning detected unsuspected, treatable tumors in 3 of 15 patients with Li-Fraumeni syndrome (LFS), a rare genetic cancer syndrome for which no screening tests have been recommended.
Potentially impacting future diagnosis and treatment of lupus, an immune illness affecting more than 5 million people worldwide, researchers at the Virginia-Maryland Regional College of Veterinary Medicine at Virginia Tech have likely uncovered where the breakdown in the body's lymphocyte molecular regulatory machinery is occurring.
› Verified 3 days ago
| Entity Name | Stillwater Medical Center Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558377135 PECOS PAC ID: 2365353794 Enrollment ID: O20040525001304 |
News Archive
PanGenetics, an antibody development company which is developing PG110, a humanized antibody to Nerve Growth Factor (NGF), today announced it has entered into an agreement with Abbott under which Abbott will acquire the global rights to this novel biologic. PG110 is currently in a Phase 1 clinical trial in patients with osteoarthritis and represents a promising new therapeutic for the treatment of chronic pain.
Valeant Pharmaceuticals International, Inc. and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older.
The team of María Domínguez, researcher for the Neuroscience Institute, joint venture of the Miguel Hernández University in Elche and the Spanish National Research Council, has managed to prove for the first time that an important factor in the development of acute pediatric lymphoblastic leukemia is inflammation.
Researchers at Dana-Farber Cancer Institute report that full-body PET/CT scanning detected unsuspected, treatable tumors in 3 of 15 patients with Li-Fraumeni syndrome (LFS), a rare genetic cancer syndrome for which no screening tests have been recommended.
Potentially impacting future diagnosis and treatment of lupus, an immune illness affecting more than 5 million people worldwide, researchers at the Virginia-Maryland Regional College of Veterinary Medicine at Virginia Tech have likely uncovered where the breakdown in the body's lymphocyte molecular regulatory machinery is occurring.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas G Wuller, MD Po Box 720006, Norman, OK 73070-4006 Ph: (405) 707-0900 | Thomas G Wuller, MD 511 S Windsor Dr, Stillwater, OK 74074 Ph: (405) 707-0900 |
News Archive
PanGenetics, an antibody development company which is developing PG110, a humanized antibody to Nerve Growth Factor (NGF), today announced it has entered into an agreement with Abbott under which Abbott will acquire the global rights to this novel biologic. PG110 is currently in a Phase 1 clinical trial in patients with osteoarthritis and represents a promising new therapeutic for the treatment of chronic pain.
Valeant Pharmaceuticals International, Inc. and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older.
The team of María Domínguez, researcher for the Neuroscience Institute, joint venture of the Miguel Hernández University in Elche and the Spanish National Research Council, has managed to prove for the first time that an important factor in the development of acute pediatric lymphoblastic leukemia is inflammation.
Researchers at Dana-Farber Cancer Institute report that full-body PET/CT scanning detected unsuspected, treatable tumors in 3 of 15 patients with Li-Fraumeni syndrome (LFS), a rare genetic cancer syndrome for which no screening tests have been recommended.
Potentially impacting future diagnosis and treatment of lupus, an immune illness affecting more than 5 million people worldwide, researchers at the Virginia-Maryland Regional College of Veterinary Medicine at Virginia Tech have likely uncovered where the breakdown in the body's lymphocyte molecular regulatory machinery is occurring.
› Verified 3 days ago
Dr. Cary Couch, Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 320 N Perkins Rd, Stillwater, OK 74075 Phone: 405-707-7500 Fax: 405-742-4990 | |
Mark Paden, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 511 Windsor Dr, Stillwater, OK 74074 Phone: 405-707-0900 Fax: 405-707-3363 | |
Scott N. Stubbs, M. D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 511 Windsor Dr, Stillwater, OK 74074 Phone: 405-707-0900 Fax: 405-707-3363 | |
John Jordan Stivers, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 511 Windsor Dr, Stillwater, OK 74074 Phone: 405-707-0900 | |
Bretton H. Jameson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 511 S Windsor Dr, Stillwater, OK 74074 Phone: 405-707-0900 Fax: 405-707-3363 | |
Dr. Bobby Doyce Anthony, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2026 S Walking Trail Dr, Stillwater, OK 74074 Phone: 405-743-3027 |